Although, to date, treatment options for people with severe obesity due to MC4R deficiency have been limited, recent evidence suggests that the dual GLP-1 and GIP receptor agonist, tirzepatide, is effective at inducing weight loss in this group (see the accompanying paper by Bhatnagar et al.51). This evidence concerns the gene MC4R and obesity disorder.